Novella
Novella56
About
What does Novella do?
Novella cultivates plant-derived ingredients using precision cell culturing, creating potent, full-spectrum bioactives without the whole plant. Their Novella ∞ product line is designed to supercharge foods and dietary supplements, boosting existing formulations to achieve greater wellness impact. They serve companies looking to enhance their products with natural, high-performance ingredients.
What is Novella's valuation?
StartupHub estimates Novella's effective valuation at $84.8M (range $52.5M to $126.0M, 21% confidence), based on comparable companies in the sector.
How much funding has Novella raised?
Novella has raised a total of $21M in funding. The most recent round on record is Funding Round.
Where is Novella headquartered?
Novella is headquartered in Tel Aviv, Israel.
When was Novella founded?
Novella was founded in 2021.
What industry does Novella operate in?
Novella operates in Food, Biotech, FoodTech, Cellular Agriculture, AgTech, Ingredient Innovation.
How many employees does Novella have?
Novella has approximately 10 people on record.
What is Novella's current status?
Novella's current operating status is: Inactive.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.